RxDoctor Payments Data

Jonathan Falakassa, MD

Orthopaedic Surgery of the Spine · van Nuys, CANPI 1285959106

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $4,000 of the $6,537 with a category attached, or 61.2%. Globus Medical accounts for 68.5% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2020 at $4,058 and has fallen 87.2% since, to $519 in 2025. That places this record below the midpoint for orthopaedic surgery of the spine clinicians in CA, where the typical reported total is $17,657.

$6,537in general payments, 2019–2025

Across 36 payments — averaging $181.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$4K
  • Baxter Healthcare$383
  • Highridge Medical LLC$259
  • Johnson & Johnson$240
  • Innovation Technologies Inc$221
  • Nevro Corp.$163
  • plus $796 from 9 others

What the payments were for

  • Consulting fees$4,00061%
  • Food & beverage$2,53739%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,537 in reported general payments places this provider in the 35th percentile of 288 orthopaedic surgery of the spine providers in California.

See all orthopaedic surgery of the spine providers in California →

Medicare billing

Part B allowed, 2024
$156,281
Medicare patients
429
Services billed
1,242

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam147$678
Gabapentin61$486
Methylprednisolone70$427
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen32$332
Diclofenac Sodium20$214
Tramadol Hcl24$197
Methocarbamol39$150
Acetaminophen-CodeineAcetaminophen With Codeine11$88
Ibuprofen11$49
Lorazepam11$7

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in van Nuys

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →